Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.38
+0.10 (1.21%)
At close: Mar 31, 2025, 4:00 PM
8.39
+0.01 (0.16%)
After-hours: Mar 31, 2025, 5:43 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$336,621
Profits / Employee
-$14,083
Market Cap
2.60B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMRX News
- 12 days ago - Amneal Pharmaceuticals: Shares Still Feel Significantly Undervalued - Seeking Alpha
- 21 days ago - Amneal to Participate at Upcoming Investor Conference - Business Wire
- 4 weeks ago - Amneal's BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA - Business Wire
- 4 weeks ago - Amneal Pharmaceuticals, Inc. (AMRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Amneal Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 5 weeks ago - Generic Drug Maker Amneal Pharmaceuticals Is Positioned To Growth Well Ahead Of Peers, Analyst Upgrades Stock - Benzinga
- 5 weeks ago - Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide - Business Wire
- 2 months ago - Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025 - Business Wire